Injectable hormonal progestational contraceptive agents
Taurand, S.
Soins. Gynecologie Obstetrique Puericulture Pediatrie 1989(93): I-Ii
1989
ISSN/ISBN: 0766-1193 PMID: 2705086 Document Number: 346571
Document emailed within 1 workday
Related Documents
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Smit, J.A.; Beksinska, M.E. 2013: Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV Journal of Acquired Immune Deficiency Syndromes 62(3): 363-365
Jensen, J.T. 2011: The future of contraception: innovations in contraceptive agents: tomorrow's hormonal contraceptive agents and their clinical implications American Journal of Obstetrics and Gynecology 205(4 Suppl): S21-S25
Wise, J. 2015: Study supports link between injectable hormonal contraceptive and HIV risk Bmj 350: H112
Mia, A.R.; Siddiqui, N.I.; Islam, M.N.; Khan, M.R.; Shampa, S.S.; Rukunuzzaman, M. 2005: Effects of prolonged use of injectable hormonal contraceptive on serum lipid profile Mymensingh Medical Journal: Mmj 14(1): 19-21
Kamischke, A.; Heuermann, T.; Krüger, K.; von Eckardstein, S.; Schellschmidt, I.; Rübig, A.; Nieschlag, E. 2002: An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations Journal of Clinical Endocrinology and Metabolism 87(2): 530-539
Konstantinus, I.N.; Balle, C.; Jaumdally, S.Z.; Galmieldien, H.; Pidwell, T.; Masson, L.; Tanko, R.F.; Happel, A.-U.; Sinkala, M.; Myer, L.; Bosinger, S.E.; Gill, K.; Bekker, L.-G.; Jaspan, H.B.; Passmore, J.-A.S. 2020: Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(7): E76-E87
Stĕrba, R. 1969: Some experiences with the effect of injectable progestational hormones Ceskoslovenska Gynekologie 34(7): 407-409
Beksinska, M.E.; Smit, J.A.; Ramkissoon, A. 2010: Progestogen-only injectable hormonal contraceptive use should be considered in analysis of studies addressing the loss of bone mineral density in HIV-positive women Journal of Acquired Immune Deficiency Syndromes 54(4): E5
Misro, M.M.; Chaki, S.P.; Kaushik, M.C.; Nandan, D. 2009: Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats Contraception 79(6): 488-497
Benagiano, G.; Kincl, F.A.; Rudel, H.W. 1968: The biology and safety of hormonal contraceptive agents Panminerva Medica 10(6): 259-270
Svendal, G.; Berk, M.; Pasco, J.A.; Jacka, F.N.; Lund, A.; Williams, L.J. 2012: The use of hormonal contraceptive agents and mood disorders in women Journal of Affective Disorders 140(1): 92-96
Beksinska, M.E.; Rees, V.H.; Nkonyane, T.; McIntyre, J.A. 1998: Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg British Journal of Family Planning 24(1): 21-23
Beksinska, M.E.; Rees, V.H.; Nkonyane, T.; McIntyre, J.A. 1998: Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg British Journal of Family Planning 24(1): 21-23
Ngcapu, S.; Masson, L.; Sibeko, S.; Werner, L.; McKinnon, L.R.; Mlisana, K.; Shey, M.; Samsunder, N.; Karim, S.A.; Karim, Q.A.; Passmore, J.-A.S. 2015: Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive Journal of Reproductive Immunology 110: 14-21
Antonio Bocaz, J.; Feldman, J.; García Huidobro, M.; Gómez, C.; Guerrero, R.; Hasbun, J.; Lehrer, N.; Martínez, L.; Méndez, G.; Noriega, C.; Onetto, E.; Puga, J.; Pupkin, M.; Rodríguez, R.; Rosenberg, D.; Stone, S.; Zañartu, J.; Altieri, E.; Barsby, F.; Pérez, I.; Vega, S. 1970: Morphological study of the human ovary under the effect of injectable long-acting progestational hormones Revista Chilena de Obstetricia y Ginecologia 35(3): 105-115
Baweja, R.; Bhattacharya, S.K.; Choudhury, S.D.; Krishna, U.; Manuel, M.; Phillips, F.S.; Datey, S.; Kumar, S.; Mehta, S.; Saxena, N.C. 1985: Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive Contraception 32(4): 383-394
Kless-Och, M. 1972: Calculation of estrogenic and gestagenic activity of oral hormonal contraceptive agents including a tabular review Schweizerische Rundschau für Medizin Praxis 61(46): 1418-1424
Hamerlynck, J.V.; Mochtar, M.H. 1992: Risk of an unintentional pregnancy after only one unprotected coitus; observations concerning today's hormonal postcoital contraceptive agents Nederlands Tijdschrift Voor Geneeskunde 136(44): 2159-2161